Endpoints News 6. Apr. 2026 Amgen seeks to buoy Tepezza with injectable data in face of incoming competition
Endpoints News 12. Dez. 2025 FDA broadens label for Amgen's Uplizna as it enters rare disease competition
Endpoints News 11. Dez. 2025 Weight loss biotech Prolynx gets $70M, snags Amgen's obesity commercial leader as CEO